期刊文献+

异位宁对实验性子宫内膜异位症大鼠的治疗作用 被引量:4

Effect of Yiweining on rats with experimental endometriosis
在线阅读 下载PDF
导出
摘要 目的:探讨异位宁治疗子宫内膜异位症的作用机制。方法:采用大鼠自体子宫内膜移植建立实验性子宫内膜异位症模型,分别观察异位宁和达那唑对模型大鼠外周血清白介素2(IL2)、白介素10(IL10)、雌二醇(E2)、孕酮(P)含量及血管内皮细胞生长因子(VEGF)在大鼠异位内膜组织中表达的影响。结果:异位宁对上述指标均有不同的下调或抑制作用,与模型组比较有显著性差异(P<0.05),异位宁高剂量组与达那唑相比无显著性差异(P>0.05)。结论:异位宁具有调节免疫、内分泌及血管内皮细胞生长因子作用,能够有效抑制异位子宫内膜的种植。 Objective: To study the effect and mechanism of Yiweining on treatment of endometriosis. Methods: To set up endometriosis model by rat selLendometria transplantation, IL-2,IL-10,E2 ,P of serum and VEGF of endometriosis tissue were detected. Results. The five parameters were depressed by Yiweining. There was significant difference of each target between Yiweining group and model group( P 〈0.05). There was no significant difference of each target between the high dose of Yiweining group and Danazol group (P 〉 0.05). Conclusion: Yiweining can inhibit the growth of endometriai transplants, which is relates with the VEGF of dometriotic tissue and serum cytokines and hormone.
出处 《山东中医杂志》 2006年第4期262-264,共3页 Shandong Journal of Traditional Chinese Medicine
基金 黑龙江省自然科学基金项目(编号:D200455)
关键词 子宫内膜异位症 异位宁 雌二醇 孕酮 白介素-2 白介素-10 血管内皮细胞生长因子 大鼠 endometriosis Yiweining E2 P IL-2 IL-10 vascular endothelial growth factor rat
作者简介 杨东霞(1977-),女,黑龙江哈尔滨人,博士研究生,主要从事中医药治疗妇科疑难杂病研究。
  • 相关文献

参考文献7

  • 1Wu MY,Ho HN.The role of cytokines in endometriosis[J].Am J Reprod Immunol,2003,49(5):285~296.
  • 2Koninckx PR,Kennedy SH,Barlow DH.Endometriotic disease:the role of peritoneal fuild[J].Hum Repoder Undate,1998,4(5):741~751.
  • 3Tan XJ,Lang JH,Liu DY,et al.Expression of vascular endothelial growth factor and thrombospondin-1mRNA on patients with endometriosis[J].Fertil Steril,2002,78(1):148~153.
  • 4刘木彪,何援利,彭冬先.子宫内膜异位症患者腹腔液血管内皮生长因子与内抑素的表达[J].第一军医大学学报,2004,24(1):69-71. 被引量:29
  • 5Hsu CC,Yang BC,Wu MH,et al.Enhanced interleukin 4 expression in patients with endometriosis[J].Fertil Steril,1997,67(6):1 059~1 064.
  • 6Ho HN,WU MY,Chao KH,et al.Peritonealinter leukin 10 increase with decrese in activated CD4+ Tlympho cytesin women withendonetriosis[J].Hum Reprod,1997,12(11):2 528~2 533.
  • 7Gurates B,Bulun SE.Endometriosis:the ultimate hormonal disease[J].Seminars in Reproductive Medicine,2003,21(2):125.

二级参考文献9

  • 1[1]Pepper MS. Manipulating angiogenesis. From basic science to the bedside[J]. Arterioscler Thromb Vasc Biol, 1997, 17(5): 605-19.
  • 2[2]American society for Reproduction Medicine. Revised American society for reproduction medicine classification of endometriosis [J].Fetil Steril, 1997, 67(8): 817-21.
  • 3[3]Dvorak HF, Brown LF, Detmar M, et al. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenasis[J]. Am J Pathol, 1995, 146(11): 1029-39.
  • 4[4]Dhanabal M, Ramchandran R, Waterman MJ, et al. Endostatin induces endothelial cell apoptosis [J]. J Biol Chem, 1999, 274(17):11721-6.
  • 5[6]Mclaren J. Vascular endothelial growth factor and endometriotic angiogenesis [ J ]. Hum Reprod Update, 2000, 6(1): 44-5.
  • 6[7]Giudice LC, Tazuke SI, Swiersz LT. Status of current research on endometriosis[J]. J Reprod Med, 1998, 43(3 Suppl): 252-62.
  • 7[9]Kupker W, Schultze-Mosgau A, Diedrich K. Paracrine changes in the peritoneal environment of women with endometriosis [J]. Hum Reprod Update, 1998, 4(5): 719-23.
  • 8[10]Barcz E, Kaminski P, Marianowski L. VEGF concentration in peritoneal fluid of patients with endometriosis [ J ]. Ginekol Pol, 2001,72(5): 442-8.
  • 9[12]Shaarawy M, E1-Sharkawy SA. Biomarkers of intrinsic angiogenic and anti-angiogenic activity in patients with endometrial hyperplasia and endometrial cancer[J]. Acta Oncol, 2001, 40(4): 513-8.

共引文献28

同被引文献64

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部